In summary, dual neprilysin inhibitor–angiotensin II receptor blocker combination therapy with LCZ696 was superior to ang II receptor blockade with valsartan alone in suppressing atherosclerosis and inhibiting the inflammatory response in apoE−/− mice. The gene discussed is MME; the disease is atherosclerosis.